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ABSTRACT 
 
Background 
Abdominal malignancies are one of the most common 
malignancy affecting humans Many patients with abdominal 
malignancies are found at exploration to be unable to undergo resection. 
Laparoscopy has been suggested as a sensitive method for detecting 
metastatic disease in this group of patients. Diagnostic laparoscopy 
effectively establishes a diagnosis, can be therapeutic, and causes less 
morbidity and mortality than a formal laparotomy. Also there is not 
much literature about cost effectiveness of the procedure & reduction in 
convalescence period. 
Objectives of study: 
• Role of diagnostic laparoscopy for staging of abdominal 
malignancy. 
• To study convalescence period & cost effectiveness of the patient. 
• To assess the ability to avoid unnecessary laparotomies. 
Methods: 
The present study evaluated 30 patients of abdominal 
malignancies admitted to Stanley Medical College Hospital during the 
period of January 2013 to December 2013 fulfilling the inclusion and 
exclusion criteria. Diagnostic Laparoscopy was performed in all 30 
patients after taking written consent. 
Diagnostic Laparoscopy was immediately followed by definitive 
or palliative surgeries when required. Categorical variables in the study 
were compared palliative surgeries when required. Categorical variables 
in the study were compared using Chi square test, contingency 
coefficient analysis, Independent sample t test, one sample t test using 
SPSS software.  P value of < 0.05 was considered to be significant. 
Results : 
Study included total of 30 patients comprising of stomach, biliary 
& colorectal malignancies with mean age of 53 years (21-70). 13 cases 
(43.3%) were found to be unresectable on staging laparoscopy and 
prevented from undergoing unnecessary laparotomy. 6 cases(20%) had 
liver metastases & 8 cases(26.7%) had peritoneal seedings on staging 
laparoscopy which were not revealed on preoperative imaging workup. 
Mean duration of Staging Laparoscopy was 18.83 min (10-30mins). 
Staging Laparoscopy had minimal major complication rates. Mean 
convalescence period was 8.2 days for study group & Mean cost for 
study group was Rs 8,897. It was significantly lower compared to open 
exploration. 
Interpretation and Conclusion: 
A short SL performed just before the planned surgical procedure 
to certify the operability is found to be safe & very effective. It is very 
accurate in assessing peritoneal seedings, hepatic metastases which are 
not found on imaging modalities. Staging laparoscopy has a significant 
impact on decisions regarding the treatment plan , helps in more careful 
planning of palliative & resectional procedure in advanced conditions, 
performing biopsy from sites of dissemination & having histological 
confirmation. It spares patients from unnecessary laparotomies and has 
been found to significantly decrease the hospital stay & cost expenditure 
when compared to open exploration. Staging  Laparoscopy should be a 
routine tool in the armamentarium of all surgeons. 
Keywords : 
Laparoscopic Surgery, Staging, Gastric,  Colorectal, Gall bladder 
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 INTRODUCTION 
Abdominal malignancies are one of the most common 
malignancy affecting humans. The purpose of this study is to determine 
if a laparoscopic approach that mimics open exploration would improve 
the accuracy of management of patient. Many patients with abdominal 
malignancies are found at exploration to be unable to undergo resection. 
Laparoscopy has been suggested as a sensitive method for detecting 
metastatic disease in this group of patients. In oncologic practice, 
minimal access surgery has been proposed for the diagnosis, staging, 
palliation, and treatment of various malignancies without any 
substantive data confirming its effectiveness. 
Diagnostic laparoscopy effectively establishes a diagnosis, can be 
therapeutic, and causes less morbidity and mortality than a formal 
laparotomy. The findings of a diagnostic laparoscopy might change the 
further course of management to a more limited approach or 
conservative line of management and help in avoiding unnecessary non-
therapeutic laparotomies. Laparoscopy is as much a surgical procedure 
as an exploratory laparotomy, often just as informative, and to the 
trained surgeon affords a better view of the entire peritoneal cavity than 
the usual exploratory incision. To achieve a high rate of positive 
diagnosis from laparoscopy requires much more than correct technique; 
it requires a thorough background of surgery, sound clinical acumen as 
also knowledge and awareness of abdominal pathology. 
One of the most meaningful and important advances realized by 
the rebirth of interest in laparoscopy is in the area of cancer diagnosis 
and staging. Diagnostic laparoscopy is being increasingly employed for 
intra abdominal malignancies. Laparoscopy can prevent unnecessary 
exploration in many abdominal malignancy patients. This novel 
technique may reveal general metastases or secondary nodules in the 
liver, peritoneum or adenopathy, thus rendering further procedures 
unnecessary and saving the patient a rather prolonged convalescence. In 
this study the role of diagnostic laparoscopy in management of 
abdominal malignancy is being evaluated. This study is also intended to 
study convalescence & cost effectiveness to patient by preventing 
unnecessary exploration. 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
AIM: 
To study the role of diagnostic laparoscopy for staging in 
abdominal malignancies. 
OBJECTIVES: 
1. Role of diagnostic laparoscopy for staging of abdominal 
malignancy. 
2. To study convalescence period & cost effectiveness of the 
patient. 
3. To assess the ability to avoid unnecessary laparotomies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
History of Laparoscopy: 
The Arabian physician Abulkasim (936-1013) is often credited 
with being the first to use reflected light to inspect an internal organ, the 
cervix. Other investigators subsequently developed instruments to 
examine the nasal recesses and the urinary bladder with the aid of 
artificial light and mirrors.  The usefulness of photography to record 
endoscopic findings was recognized early, and by 1874 Stein had 
modified existing cameras to record images of bladder pathology. 
In 1901 Kelling reported using a cystoscope to inspect the peritoneal 
cavity of a dog after insufflation with air. He then coined the term 
“celioscopy”, to describe this technique. The first report of using this 
procedure in man was by the Swedish physician Jacobaeus in 1910. 
These early procedures, however, were entirely diagnostic in nature; the 
exposure obtained and the instruments available did not allow operative 
intervention. The early pioneers introduced their trocars and cystoscopes 
directly into the peritoneal cavity.  It was another 30 years before 
pneumoperitoneum was used prior to insertion of the first cannula. 
Goetz and later Veress developed an insufflation needle for the safe 
introduction of gas into the abdomen. 
The  introduction  of  an  endoscope through the abdominal wall 
was initially associated with a number of major and minor 
complications. The risk of injury to underlying bowel and vascular 
structures has always been a major concern of clinicians performing this 
procedure. In 1946 Decker introduced an a1ternative method of placing 
the laparoscope into the abdominal cavity in an attempt to minimize this 
complication. He inserted the scope into the pelvis through the cul-de- 
sac and named the procedure culdoscopy. 
Kurt Semm in Kiel, Germany, developed an automatic 
insufflation device that monitored abdominal pressure and gas flow. 
Prior to this time air was introduced into the peritoneal cavity by means 
of a syringe.  The introduction of fiber optic (cold) light sources in the 
early 1960s eliminated the risk of bowel burns caused by incandescent 
lighting, bowel injuries related to unipolar coagulation. In 1986, the 
problem of laparoscopic visualization of abdominal cavity was solved 
with the development of a computer chip TV camera attached to the 
laparoscope. 
The  fear  of  uncontrolled  bowel injuries from monopolar 
coagulation also prompted many gynecologists to adopt the laser as a 
dissecting and coagulation device. The first clinical report describing 
laser energy for operative pelvioscopy was by Bruhat, Mage, and 
Manhes in 1979.  Subsequently, laser light has been used for 
coagulation and enucleation of endometrial implants, treatment of 
ectopic pregnancy with preservation of the affected adnexa, 
adhesiolysis. 
The  first  laparoscopic  procedure performed by general surgeons 
appears to have been liver biopsies guided under direct vision. Clinical 
investigators rapidly recognized the versatility of this procedure in 
obtaining tissue from other areas of the abdominal cavity. Warshaw, 
Tepper, and Shipley utilized laparoscopy in 1986 for staging of 
pancreatic carcinoma and demonstrated an overall accuracy rate of 93%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EQUIPMENTS USED IN LAPAROSCOPY 
 
Laparoscopic Instrumentation and Operating Room Setup 
Laparoscopic instrumentation continues to evolve at a rapid pace, there 
is, however, a basic set of equipment necessary for safe and effective 
diagnostic laparoscopy. 
1. 0-degree or 30-degree angled laparoscope either 5 or 10 mm in 
diameter 
2. 5-mm laparoscopic instruments including maryland dissector, 
blunt-tip dissecting forceps, cup-biopsy forceps, atraumatic 
grasping forceps, liver retractor, and scissors 
3. 5- or 10-mm suction/irrigation device 
4. Laparoscopic ultrasound probe (optional)        
 
 
 
 
 
 
 
 
 
 
 
 
Fig 1. Standard instruments used for diagnostic laparoscopy 
 
 Individual choices as to whether disposable, reusable, or 
combination disposable/reusable instrumentation is preferable should be 
based on surgeon preference, cost, and availability. Standard 
instruments are shown in Fig.1. The basic tray consists of a scissors, 
grasper, and dissector. As electrocautery is used during the procedure, 
all instruments are insulated to the tip. This setup fulfills our needs and 
is extremely cost-effective. 
Laparoscopic telescopes are either forward-viewing (0-degree) or 
oblique (30- to 45-degree). Oblique views are essential to visualize 
relatively inaccessible regions of the abdomen, such as the dome of the 
liver. In our opinion, the oblique telescope is an essential part of 
diagnostic laparoscopy, particularly in cancer staging. It is important to 
note that the first and rate-limiting step in obtaining a clear image on the 
monitor relies on the quality of the telescope and, thus, diligent 
maintenance and handling should be the rule when handling the 
telescopes. In addition, simple measures such as warming the telescope 
prior to insertion are effective in maintaining image quality. Currently 
generally use the 10-mm telescope is done; however, recent 
improvements in optical technology have enabled excellent 5-mm 
angled telescopes to be developed that are now gaining popularity. 
Patient Positioning 
The procedure is generally performed under general anesthesia 
with the patient positioned supine on the operating table. A warming 
blanket is placed underneath the patient, who is secured appropriately to 
the table with padding over the pressure points. 
For the majority of diagnostic procedures, the surgeon stands on 
the right side of the patient with the assistant on the left side Fig.2. 
Monitors are positioned to the head of the table with the equipment 
tower placed opposite the operating surgeon to facilitate easy viewing. 
For pelvic procedures, the monitors can be placed towards the foot of 
the patient. 
Abdominal Access: 
Pneumoperitoneum can be established by either an open or closed 
technique. Irrespective of the method used, the abdominal skin is 
prepared and draped in standard fashion as for a laparotomy, should it 
be required. A urinary catheter is generally not placed. However, the 
patient is asked to empty the bladder prior to induction of anesthesia in 
order to minimize the risk of inadvertent bladder injury.                  
               
The needle-trocar method is a closed technique initially described 
by Veress in 1938. The concept is that needle insufflation creates a 
pneumoperitoneum, which elevates the anterior abdominal wall while 
compressing the viscera, allowing safe placement of the initial 
laparoscopic port. With the patient in the trendelenburg position, the 
veress needle is inserted in the midline, below the umbilicus, aiming 
toward the pelvis at 45 degrees to the horizontal. During insertion, the 
abdominal wall should be grasped on either side, with towel clips if 
necessary, and lifted away from the viscera. As the needle passes 
through the fascia and into the peritoneal cavity, the surgeon should feel 
a loss of resistance to the needle. Correct peritoneal placement can be 
assessed by a number of methods, none of which are failsafe. First, the 
needle can be aspirated to exclude bladder, visceral, or vascular 
placement. The saline drop test indicates lack of resistance to flow and 
probable correct placement. 
Saline, in a 5-mL syringe on the end of the needle, is sucked into 
the abdomen when the needle tip enters the vacuum created by the lifted 
abdominal wall. Finally, intra-abdominal pressures should be measured. 
In general, pressures below 5 mm Hg are considered normal. 
 
Following confirmation of satisfactory placement, the needle is 
connected to the automatic insufflator. Initial insufflation should be set 
at a low flow rate until peritoneal entry is confirmed. If a high pressure 
reading is seen initially, it suggests that the needle is not in the 
peritoneal cavity and may be in the preperitoneal space. The needle then 
requires repositioning. A low pressure reading allows high flow to be 
activated and the CO pneumoperitoneum can then be achieved to a level 
of 10 to 15 mm Hg, at which time flow automatically discontinues. 
Once adequate pneumoperitoneum is established, a small skin 
incision is made in the midline, below the umbilicus, and a 10- to 12-
mm trocar is then inserted in the same manner as the veress needle. 
Trocars may have a spring-loaded “safety shield” that protects the sharp 
edge of the trocar on entering the peritoneal cavity and locks in position 
to prevent organ injury 
A second closed technique is direct trocar insertion without using 
a veress needle. After incising the skin, the abdominal wall is grasped 
and pulled up to lift it away from the viscera while the trocar is inserted 
as previously described in Fig.3. Proponents of this method suggest that 
grasping the normal abdomen is easier and more effective than grasping 
an abdominal wall that is distended by the pneumoperitoneum. 
Despite the blind nature of both closed techniques, they are 
remarkably safe. However, serious complications have been reported. 
These complications include vascular and visceral injuries such as 
bowel injury, bladder perforation, hematoma, and extraperitoneal 
insufflation. The advantages and risks should be understood and their 
use individualized by the surgeon. 
An alternative to the closed technique is the open cut-down 
usually performed subumbilically with a blunt trocar. This technique, 
popularized by Hasson in the early 1970s, is favored by us. Although it 
does not eliminate the possibility of visceral injury, it allows controlled 
entry under direct vision. A small skin incision is made below the 
umbilicus. A transverse “smile” incision is more cosmetic but a midline, 
longitudinal incision is easier to extend, should it be required. The 
umbilical stalk is followed down to the linea alba, which is then 
carefully incised using cautery. The dissection is performed under direct 
vision. The peritoneum is breached with a hemostat 
Using a J-shaped needle, a 0-0 absorbable suture is placed in the 
fascia on each side. Upward force on these enables a blunt port and 
trocar to be inserted; they are then tied to the port, securing it in 
position. Threaded ports can be screwed to form an airtight seal, the 
trocar is removed, and CO is insufflated as previously described. No 
single technique has been proven to be safer than another, and serious 
complications can occur in each, with the experience of the surgeon 
generally proving a major factor. 
Diagnostic Laparoscopy for Malignant Disease 
The technique of laparoscopic staging should mimic the operative 
assessment performed at open exploration. For upper gastrointestinal 
cancers, a multiport technique is used. This approach allows for a 
thorough examination of the peritoneal cavity. 
The patient is placed supine on the operating table. As mentioned 
previously, we prefer to obtain access to the peritoneal cavity by an 
open modified Hasson technique through a subumbilical incision. The 
initial 1- to 2-cm incision is extended down to the fascia, which is 
incised in a vertical manner with the peritoneum under direct vision. A 
blunt port is inserted through the umbilical port and attached to a high-
flow insufflator at a set flow rate of 10 to 15 L/min. 
A 5- or 10-mm 30-degree angled telescope is used. Secondary 5- 
to 10-mm trocars are placed in the right (5- and 10-mm) and left (5-mm) 
upper quadrants along the line of a bilateral subcostal incision. 
 A four-quadrant systematic examination of the peritoneal cavity is 
performed for obvious peritoneal extension of disease. Peritoneal 
washings for cytologic examination are taken from the right and left 
upper quadrants after instillation of 200 ml into the peritoneal cavity 
prior to manipulation of the primary or metastatic tumour. Prior to 
aspiration, the abdomen is gently agitated. In patients with gastric 
cancer, a pelvic aspirate is also taken as this has been shown to increase 
the cell yield. The primary tumour is then assessed. Local extent, size, 
and fixation and possible extension to contiguous organs are considered. 
The patient is placed in a 20-degree reverse trendelenberg 
position with 10 degree of left lateral tilt. This is important as it 
optimizes the exposure of the liver. The liver is “palpated” by using a 
blunt or rounded 10-mm instrument. This allows for indirect haptic 
feedback. The examination is sequential, with the anterior and posterior 
surfaces of the left lateral segment of the liver examined first, followed 
by the anterior and inferior surface of the right lobe. Improved 
visualisation of the dome of the liver may be achieved by moving the 
camera to the right upper quadrant port. The majority of the liver 
surface, with the exception of the posterior aspect of segments VII and 
VIII, can be examined. The hilus of the liver, hepatoduodenal ligament, 
and foramen of Winslow are then visualized. Periportal nodes can be 
biopsied or excised if required. 
The patient is then re-positioned in a 10-degree Trendelenberg 
position without lateral tilt, and the omentum is retracted toward the left 
upper quadrant in order to examine the colonic mesocolon. This is 
helped by elevating the transverse colon, which allows the ligament of 
Treitz to be identified. Care should be taken in grasping the bowel so as 
to avoid any visceral injury. The mesocolon is carefully inspected and 
any suspicious nodules or nodes can be biopsied if clinically indicated. 
On completion of this portion of the assessment, the patient is returned 
to a supine position. For the majority of patients with upper 
gastrointestinal tumours, this is the limit of the diagnostic procedure. 
However, for patients with pancreatic disease, there is added value to 
assess the lesser sac and celiac axis. To facilitate this maneuver, the left 
lobe of the liver is elevated and the gastrohepatic omentum is incised to 
gain entrance into the lesser sac. Hemostasis is achieved with the use of 
electrocautery or ultrasonic dissection. The caudate lobe of the liver, 
inferior vena cava and celiac axis can be examined. The use of an angled 
telescope is recommended as this facilitates examination of the anterior 
aspect of pancreas, hepatic artery, and left gastric artery. The course of 
the hepatic artery is visualized to the porta. Celiac, portal, perigastric, 
and hepatogastric nodes can be sampled if they appear suspicious. 
After inspection to ensure adequate hemostasis, the ports can be 
removed under direct visualization using the laparoscope to ensure there 
is no visceral herniation or bleeding. As much of the pneumoperiteum as 
possible should be expelled from the abdomen to reduce postoperative 
shoulder pain. The easiest way to achieve this is to squeeze the abdomen 
before removing the umbilical trocar. We do not instill local anesthetic 
into the peritoneal cavity on completion of the procedure. 
The fascia of any port site greater than 5 mm should be closed 
with an absorbable suture on a J-shaped needle. The skin is closed with 
either continuous or interrupted subcuticular sutures; steristrips may be 
applied and local anesthetic injected around the wound.  
Systemic changes during laparoscopic surgery 
Respiratory system: 
During  laparoscopic  procedures performed under general 
anesthesia, controlled ventilation is often recommended to prevent 
hypercapnia, which can result from a combination of factor (e.g., 
narcotic analgesics, mechanical impairment of ventilation from CO 
induced abdominal distension and systemic absorption of CO from the 
peritoneal cavity). 
If  patients  have  a  limited  pulmonary reserve, the necessary 
increase in respiratory work may not be obtainable and respiratory 
failure may occur. The increase in PaCO cannot be prevented if high 
doses of sedatives are given because of central respiratory depression. 
Continuous monitoring of peripheral O saturation is advisable in 
all patients since hypoxemia can occur from elevation of the diaphragm 
(loss of functional residual capacity) as a result of pneumoperitoneum. 
This is more likely to occur during spontaneous ventilation rather than 
controlled mechanical breathing. 
Carbon dioxide embolus 
CO is commonly used for laparoscopic surgery because it has a 
relatively innocuous effect on peritoneal surfaces and is highly soluble 
in the bloodstream. Intravascular entry of small amounts is generally not 
hazardous because CO rapidly absorbed via the splanchnic vascular bed. 
However, excessive intra-abdominal pressures or anesthetic techniques 
that reduce splanchnic blood flow may reduce its absorption and 
increase the likelihood of symptomatic gas embolus. 
The presenting signs of CO embolus include a sudden, profound 
fall in blood pressure, dysrhythmia, mill wheel or other heart murmurs, 
cyanosis and /or pulmonary edema. End-tidal CO (etCO ) may increase 
abruptly as CO embolises. If the gas embolus is large, the etCO increase 
may be followed by an abrupt decrease. If right heart dysfunction is 
severe, blood is no longer delivered to the lungs. An important etiologic 
factor in the development CO embolus is high insufflation pressures.  
Excessive bleeding should alert the anesthesiologist to the possibility of 
a CO embolus. 
Cardiovascular System 
The reverse trendelenburg position required for laparoscopic 
procedures may result in decreased venous return, cardiac output, and 
blood pressure. In addition, insufflation of the abdominal cavity leads to 
an increase in total peripheral resistance, particularly if intra-abdominal 
pressures are high and the aorta is compressed. The effect of patient 
positioning and pneumoperitoneum on venous return and blood pressure 
is largely dependent on the patients’ intravascular volume status prior to 
insufflation of CO . Volume loading with 10 to 20 ml/kg crystalloid 
solution prior to positioning minimizes these cardiovascular changes. 
Cardiac dysrhythmia can occur during laparoscopy. Respiratory 
acidosis and the resultant sympathetic stimulation are thought to be the 
primary etiologic factors. Hypoxia and vagal stimulation may be other 
contributing causes. Of the inhalation anesthetics, enflurane and 
isoflurane have a lower incidence of dysrhythmia than halothane, which 
increases endogenous catecholamines. During general anesthesia with 
controlled ventilation, cardiac dysrhythmia can be prevented by 
carefully regulating the PaCO . 
Gastric Reflux 
Gastric reflux is a significant concern when laparoscopy is 
performed using regional anaesthesia. Predisposing factors include 
obesity, hiatal hernia, increased intragastric pressure, excessive 
pneumoperitoneum, and aerophagia. The incidence of reflux and 
aspiration pneumonitis in high-risk patients can be minimized by careful 
selection of the anesthetic technique, prophylactic antacids and H2 
blockers. In patients with suspected delayed gastric emptying (obese 
patients and those with hiatal hernia or diabetes mellitus), preoperative 
administration of metoclopramide, 10mg orally or intravenously, 
increases lower esophageal sphincter tone and gastric emptying and may 
reduce the likelihood of reflux. 
Complications of diagnostic laparoscopy 
1.  Anesthesia 
 a. Complications of general anesthesia/sedation 
 b. Vaso-vagal shock under local anesthesia 
2. Insertion of pneumoperitoneum needle 
 Tip of needle, malpositioned in  Consequence 
 a. Pre -peritoneum  Emphysema 
 b. Hollow viscus  Perforation/distension 
 c. Localized adhesion  Localized pneumoperitoneum 
 d. Omentum  Omental emphysema 
 e. Blood vessel  Bleeding, air embolism 
 f. Retroperitoneum  Mediastinal emphysema 
3. Pneumoperitoneum 
a.  Cardio respiratory embarrassment due to elevation of 
diaphragm, compression of inferior vena cava, hypercarbia if 
carbon dioxide is used. 
b.  Air embolism 
4. Main  trocar  insertion 
a.  Hollow viscus perforation (stomach, bowel, and bladder) 
b.  Solid viscus injury (liver/spleen when grossly enlarged) 
c.  Blood vessel injury (In abdominal wall - varix, epigastric 
vessels, In peritoneal cavity - mesenteric vessels, 
retroperitoneal - aorta. vena cava. iliac vessels) 
5. Examination 
a. Injury with telescope 
b. Flash burns during photography 
6. Second  puncture 
Unlikely as under vision -  Abdominal wall, blood vessel injury. 
7. Transperitoneoscopic procedures 
a. Bleeding after biopsy/diathermy 
b. Biliary leak 
c. Perforation after biopsy/diathermy 
d. Bleeding/perforation while severing adhesions 
e. Explosion with diathermy 
8. Release of pneumoperitoneum 
 Pain if large volume of gas left behind 
9. Exit 
a. Ascites leak 
b. Omental prolapse 
10. Postperitoneoscopy 
a. Immediate - evidence of any of above complications 
b. Delayed – Infection, Ascites leak, Incisional hernia, Richter’s 
hernia 
CONTRAINDICATIONS TO LAPAROSCOPY 
Absolute 
• Unstable cardiopulmonary states 
• Uncorrectable or severe coagulopathy 
• History of generalized peritonitis 
• Patients having undergone multiple previous laparotomies 
• Bowel obstruction with massive intestinal dilatation with 
abdominal distention 
• Abdominal wall infection, advanced pregnancy 
Relative 
• Chronic cardiopulmonary disorders 
• Correctable or minimal coagulopathy 
• Prior abdominal surgery 
• Abdominal hernias 
• Obesity 
• Tense ascites (transudate from portal hypertension). 
ANAESTHESIA 
The general principles and consideration regarding the choice of 
anaesthesia for traditional open procedures also apply to laparoscopy. 
As with any operative procedure, success depends on team cooperation 
and commitment. No special monitoring is required simply because the 
procedure is being performed under laparoscopic guidance. 
The choice of the anaesthesia technique should be commensurate 
with the goal of returning patients to their normal life-style as rapidly as 
possible. The anaesthesia effects should dissipate shortly after the end of 
the procedure. 
General Anaesthesia 
General anaesthesia is advantageous because the cardiorespiratory 
status can be better controlled. Continuous end tidal CO (etCO ) 
monitoring allows appropriate adjustments of minute ventilation to 
maintain normal PaCO levels and facilitates the rapid detection of CO 
embolus. A transient but rapid increase in etCO suggests a CO embolus. 
Controlled ventilation may reduce the incidence of dysrhythmia in 
comparison to spontaneous ventilation, particularly in the presence of 
central nervous system depressants and respiratory acidosis. 
Endotracheal intubation offers optimal protection of the airway. 
Appropriate depth of anaesthesia and the use of muscle relaxants 
minimize motion within the operative field and may shorten the 
operative time. 
Local anaesthesia 
This method is useful only in procedures of very short duration, 
primarily those of a diagnostic nature. 
DIAGNOSTIC AND STAGING LAPAROSCOPIC PROCEDURES 
IN CANCER 
During the last decade, laparoscopy has replaced open laparotomy 
as the preferred approach in patients who require surgical diagnosis and 
staging of cancer. The role of laparoscopy as a biopsy tool is reserved 
primarily for patients in whom a tissue diagnosis is needed to direct 
therapy but cannot be obtained by image-guided needle biopsy or by 
endoscopic means.  
The liver and peritoneal surfaces are the most readily accessible 
sites for laparoscopic tumour biopsy. Other sites, which may be 
accessible to the laparoscope but may require more dissection for 
exposure and access include the intestinal mesentery and the 
retroperitoneum. Lymph nodes or other lesions in the para-aortic and 
caval regions of the retroperitoneum are especially difficult to access, 
whereas celiac and iliac nodes are more readily biopsied. Laparoscopy 
has also been used as a second-look procedure to evaluate responses to 
therapy. Aspiration of ascites or peritoneal lavage can be performed and 
fluid sent for cytological analysis for possible intra-peritoneal shedding 
of tumour. 
Staging Laparoscopy 
Staging laparoscopy has become an important tool in the 
evaluation of patients with certain gastrointestinal malignancies who are 
being considered for curative resection. The magnified view of the 
laparoscope enables the surgeon to detect small liver or peritoneal 
metastases that are not visible with current non-invasive imaging 
modalities. In addition, the use of laparoscopic ultrasound may allow 
imaging of occult liver metastases or local tumour invasiveness that 
would preclude curative resection. In large series of patients with mixed 
upper gastrointestinal malignancies undergoing staging laparoscopy, the 
incidence of occult metastases not seen on preoperative imaging has 
been approximately 20%. 
The accuracy of pre-operative staging was improved by 
laparoscopy in 41% of patients in one series of 389 patients, including 
several patients who had suspicious lesions on preoperative imaging that 
proved benign. 
Laparoscopic staging can be helpful in lymphoma, oesophageal 
cancer, gastric cancer, pancreatic adenocarcinoma, hepatocellular 
carcinoma, carcinoma of the gallbladder, extrahepatic bile duct cancer, 
and selected periampullary cancers as well as in second look operations 
after chemotherapeutic regimens. 
Most occult metastases are identified by laparoscopy with biopsy 
alone; however, the addition of laparoscopic ultrasound to the staging 
protocol may allow detection of disease elsewhere, particularly vascular 
invasion, that would also contraindicate resection. Some authors have 
advocated that diagnostic laparoscopy and laparoscopic ultrasonography 
should be used as an adjunct to pre-operative imaging studies in all 
patients with primary or metastatic intra-abdominal neoplasms because 
as compared with pre-operative imaging, the combination of diagnostic 
laparoscopy and laparoscopic ultrasonography provides more accurate 
information regarding staging and resectability, thereby helping to 
determine the extent of operation and reduce the number of unnecessary 
laparotomies. 
Diagnostic laparoscopy (DL) plays two important roles for patients: 
1. It spares patients from the experience of undergoing an 
exploratory laparotomy and 
2. Identifies patients with locally advanced disease for neoadjuvant 
therapy. 
There is good category II/III evidence that video-laparoscopic 
staging is valuable in certain gastrointestinal (gastric, esophageal, 
pancreatic and hepatobiliary) and intra-abdominal lymphomas, but no 
category I evidence (based on prospective randomized trials). The 
evidence available is all retrospective, but of sufficient consistency to 
indicate that laparoscopic staging adds to the primary ( imaging ) 
staging and often alters the clinical stage of the disease and hence the 
management of the individual patient. 
Siewert affirms that beyond any doubt surgical laparoscopy 
constitutes a step forward in surgical methodologies and contributes to 
improve preoperative staging, especially for peritoneal carcinomatosis. 
It should be used if therapeutic benefits can be gained, as is true for 
neoadjuvant chemotherapy. Otherwise, benefits and risks must be 
evaluated carefully. Irresponsible usage of surgical laparoscopy is not 
beneficial for the doctor or for the patient. 
Rosin et al. define important technical aspects regarding 
diagnostic laparoscopy. The first controversial issue is its timing: it can 
be a separate procedure, or performed immediately before the planned 
curative surgery. Another unresolved debate is the extent of the 
procedure: it ranges from inspection only, with biopsy of suspicious 
lesions, to extensive dissection, use of LUS, and peritoneal cytology 
sampling. 
Luis F. Onate-Ocana et al define a four group staging system: 
stage I, no serosal involvement; 
stage II, serosal involvement; 
stage III, adjacent organ invasion; and 
stage IV, distant disease 
The proposed staging system is a simplification of the TNM 
staging and is not intended to be a substitute. It should be regarded as a 
tool for the selection of the best therapeutic option for the specific 
patient and also for pretherapeutic stratification of risk factors in the 
setting of new randomised clinical trials. 
Gastric  malignancies 
Gastric cancer continues to be a significant health problem around 
the world. It  is one of the leading causes of cancer death and most 
common malignancy among men and the second most common among 
women worldwide. In countries other than Japan, the presentation of 
gastric cancer is usually late and the overall prognosis of the disease is 
poor. 
Primary carcinoma of the stomach can be cured by surgical 
resection if it is found early. The first priority of surgery for gastric 
cancer must be to resect the entire primary tumour such that there is no 
macroscopic or microscopic tumour remaining. Unfortunately, these 
tumours often have spread by the time the diagnosis is made.  
Staging workup in gastric carcinoma is based mainly on the 
anatomic extent of the disease, such as serosal infiltration, lymph node 
metastases, peritoneal seeding, ascites, and the presence of liver 
metastases. Evaluation of surgery and other treatments depends on 
accurate staging of tumour, associated lymph nodes, and distant 
metastases. 
 A more accurate preoperative staging allows a better prepared 
setting to avoid unnecessary laparotomy, to decide preoperative 
neoadjuvant chemotherapy, and to prepare the operation for combined 
resections or intraoperative radiotherapy. Preoperative ultrasonography 
& CT scanning have been shown to be poor predictors of resectability in 
patients with gastric cancers. 
Because of the inaccuracy of CT and other modalities for the 
detection of macro metastases smaller than 5mm on the peritoneal 
surface or liver, laparoscopy is recommended as next step in evaluation 
of patients with locoregional disease. 
Many authors, therefore, have advocated the use of diagnostic 
laparoscopy in addition to noninvasive modalities to assess  these 
patients for metastatic disease. 
Some reasons advocate the staging laparoscopy in gastric cancer 
treatment. 
• Because of the natural progression of this disease the risk of 
finding peritoneal implants (M1 disease) at the time of 
laparotomy is 25-37% after an otherwise, unremarkable CT scan. 
• Considering the fact that few patients with M1 disease actually 
develop surgical bleeding or significant gastric outlet obstruction 
prior to death a strong argument can be made for laparoscoping 
all patients with advanced gastric cancer. 
• Moreover in order to select patients that will most likely benefit 
from 
• neoadjuvant treatment, distant metastases must be ruled out 
preoperatively. 
In the neoadjuvant treatment setting, staging must correctly identify 
(1) Incurable tumours with distant metastatic disease and 
(2) High-risk tumours with serosal infiltration. 
Surgical laparoscopy offers high accuracy for detecting 
intraabdominal small metastases. Laparoscopic inspection is better than 
macroscopic examination under open laparotomy for several reasons. 
The subphrenic space and Douglas pouch, where peritoneal metastases 
is frequently observed but direct observation under laparotomy misses 
small metastatic nodules, can be observed by laparoscopy depending on 
the magnifying power. Therefore, staging laparoscopy should be 
performed for patients at high risk for peritoneal metastases, such as 
patients with type 4 tumours, undifferentiated tumours, or tumours in 
more than two regions. 
Several studies showed that preoperative chemotherapy induced 
down-staging of the disease and resulted in a higher curative resection 
rate for surgically staged unresectable cancer. Accurate staging is 
necessary in advanced cases not only to decide on neoadjuvant 
treatment but also on whether to proceed with salvage surgery after 
neoadjuvant treatment. A second staging laparoscopy effectively 
determined whether patients should undergo salvage surgery after 
neoadjuvant therapy, especially in cases where peritoneal metastases 
was the only reason for noncurability. 
Over the last 2–3 decades, reports have highlighted the role of 
diagnostic laparoscopy in the early detection  of gastric cancer. The 
technical refinement of the laparoscope over the past decade and the 
enhancement of technique made laparoscopy the ideal tool for the 
absolute diagnosis and staging of malignancy. 
Primary Hepatic Tumours 
The use of SL has been advocated to select patients with 
hepatocellular carcinoma for resection. The literature evaluation of SL 
for hepatocellular carcinoma is not as extensive as for other 
malignancies. Recent reports have suggested that laparoscopy has much 
to offer in the staging of primary and secondary liver tumours Despite a 
sophisticated diagnostic armamentarium which includes duplex 
ultrasonography, computerized tomography(contrast-enhanced, 
portography), magnetic resonance imaging, and selective visceral 
angiography, 40%-70% of hepatic tumours are found to be unresectable 
at the time of open exploration. 
Peritoneal spread is relatively rare in hepatocellular carcinoma, 
however, the risks of laparotomy in patients with altered liver function 
subject to postoperative ascites should be considered as increasing the 
potential benefit of SL. 
In addition to tumour assessment, SL in patients with 
hepatocellular carcinoma provides a minimally invasive assessment of 
the severity of cirrhosis and the size of the liver remnant which is 
critical for the assessment of resectability. Similar to pancreatic cancer, 
operative resection in hepatobiliary malignancy is associated with 
improved survival only in selected patients in which complete tumour 
resection can be performed with an adequate hepatic remnant for 
recovery. The presence of sub-radiographic metastatic disease is also of 
concern in certain patients with hepatobiliary malignancy. 
Considerable controversy currently exists as to the criteria for 
resectability of liver tumours. In many centers, the presence of 
extrahepatic tumour spread, multifocal or bilobar disease, or the 
presence of significant cirrhosis constitute absolute contraindications for 
curative resection. In other centers, these factors are considered relative 
criteria. Thus, the impact of a staging modality such as laparoscopy is 
difficult to ascertain from the literature. Nonetheless, some insight on 
the efficacy of laparoscopy in diagnosing and staging hepatic tumours 
and avoiding unnecessary open exploration in those patients with 
advanced disease can be obtained from published data. 
The role of diagnostic laparoscopy and liver biopsy in the 
diagnosis and staging of cancer deserves special mention. Patients 
suspected of having hepatic malignancy should have screening 
radiological investigations before proceeding to diagnostic laparoscopy. 
However, the sensitivity of radiological investigations is low in 
the diagnosis of peritoneal metastases originating from hepatic 
neoplasms. Two studies from the same centre identified 21% and 48% 
of patients with negative CT scans as having peritoneal metastases at 
laparoscopy. In these cases, diagnostic laparoscopy avoided the 
necessity for laparotomy. 
Treatment of hepatocellular carcinoma (HCC) by surgical 
resection is generally precluded by background cirrhosis, peritoneal 
metastases and multi-focal disease; all of which may be assessed by 
laparoscopy. 
In a study by D’Angelica et al of 410 patients with 
radiographically resectable hepatobiliary malignancy, SL was completed 
in 73% of patients and, in 84 (55%) of the 153 evaluated patients, SL 
identified disease that precluded resection. In this group of patients, SL 
was valuable in identifying unsuspected cirrhosis, peritoneal disease and 
additional hepatic tumours but it commonly failed to identify extra- 
regional lymph node metastases and vascular invasion. 
Lo et al reported that SL and laparoscopic ultrasonography 
allowed for the avoidance of laparotomy in 63% of patients with 
unresectable disease. In their experience, the accuracy of SL was 
decreased in tumours > 10 cm and in the evaluation of tumour thrombi 
in major vascular structure and/or the invasion of adjacent organs. In 
patients who were spared laparotomy, a faster postoperative recovery 
and an earlier initiation of nonoperative treatment was observed and the 
authors suggest that the procedure should be performed routinely before 
laparotomy for hepatocellular carcinoma. 
Staging laparoscopy has recently been employed as a staging tool 
in HCC and spares about one in five patients a nontherapeutic 
laparotomy. Laparoscopy yields additional information about extent of 
disease in the liver, extrahepatic disease, and cirrhosis. The yield of 
laparoscopy is dictated by the extent of disease and is only selectively 
employed. The presence of clinically apparent cirrhosis, radiologic 
evidence of vascular invasion, or bilobar tumours increased the yield to 
30%, whereas without these  factors, the yield is 5%. 
Biliary Tract Tumours 
Patients with malignancies of the biliary tract have a dismal 
prognosis. As in most abdominal cancers, resection is the only effective 
treatment with potential for cure. Preoperative staging is not completely 
accurate, however, and a significant number of patients with biliary 
carcinoma undergo unnecessary laparotomy. As imaging technology 
improves, more patients with unresectable disease will be identified, 
avoiding the need for a laparotomy. Laparoscopy is a major addition, 
but its usefulness in staging of abdominal malignancies continues to 
evolve. 
Hilar cholangiocarcinoma and gallbladder carcinoma are 
aggressive malignancies, with a median survival for patients with 
unresectable disease of 11 months and 5 months, respectively. 
Unfortunately, even after extensive preoperative evaluation, occult 
unresectable disease is discovered at the time of exploratory laparotomy 
in many patients. Because of the recovery time required after major 
laparotomy and the limited median survival in patients with unresectable 
disease, many centers have been evaluating the role of staging 
laparoscopy. 
Even after extensive preoperative imaging, many patients are 
found to have either unresectable, locally advanced tumours or 
metastatic disease at laparotomy. After thorough preoperative imaging, 
only 50% to 75% of patients who undergo exploration are amenable to a 
potentially curative resection. 
Preoperative assessment of respectability of biliary tract tumours 
is challenging since, in addition to metastatic spread, the resectability of 
a given tumour is predicated on hilar vascular and biliary involvement  
which is often not accurately assessed by preoperative imaging. Despite 
extensive preoperative evaluation, less than half of patients who 
undergo exploration are amenable to a potentially curative resection and 
the issue of respectability is usually resolved at laparotomy, often after 
an extensive dissection of the portal vascular and biliary structures. 
Because early carcinoma of the gallbladder causes no specific 
signs or symptoms, most patients with this disease are diagnosed with 
advanced-stage tumours. Resection remains the most effective therapy 
for patients with extrahepatic biliary cancer. However, because many 
patients present late in the course of the disease, resection is often not 
possible. 
Tumours were considered unresectable if any of the following 
conditions were present before surgery or at laparoscopy or laparotomy: 
peritoneal metastases; discontiguous intrahepatic metastases; involved 
lymph nodes in the periduodenal, retropancreatic, common hepatic, or 
celiac nodal basin; locally advanced disease secondary to main portal 
vein encasement or tumour extension to second-order biliary radicles 
bilaterally; or unilateral tumour extension to secondary biliary radicles 
with contralateral lobar atrophy or contralateral portal vein involvement. 
In patients with gallbladder cancer, the yield of laparoscopy was 
highest in those not subjected to prior cholecystectomy. More than half 
the patients with primary gallbladder cancer benefited from staging 
laparoscopy, supporting its routine use in this subgroup. Patients 
undergoing reexploration after initial cholecystectomy represent a more 
difficult problem. 
The advantages of detecting unresectable disease at laparoscopy 
include not only the shortened recovery time and improved quality of 
life(decreased morbidity and pain), but also the potentially shorter time 
to initiation of nonoperative therapy. 
In summary, patients with hilar cholangiocarcinoma and 
gallbladder cancer frequently have unresectable disease that is not 
apparent on preoperative imaging studies. Laparoscopy correctly 
identifies unresectable disease and prevents unnecessary laparotomy in 
one third of patients. Patients with unresectable disease that is not 
detected at laparoscopy most often have locally advanced tumours. 
Patients with primary gallbladder cancer and patients with T2/T3 hilar 
cholangiocarcinoma should undergo staging laparoscopy before 
laparotomy. 
Regarding the differential use of SL in cholangiocarcinoma and 
gallbladder cancer, most of the authors observed a higher yield of SL in 
gallbladder cancer. This is likely due to a more frequent early 
dissemination in gallbladder cancer. 
Staging laparoscopy should be performed in patients with 
gallbladder cancer, as high proportions(50-55%) of patients have hepatic 
or extrahepatic disease that is not detected by noninvasive staging 
modalities. 
Colorectal cancers 
SL is primarily not used in colorectal cancers . The indication for 
SL is to prevent bleeding obstruction and perforation. In case of primary 
colorectal cancers with liver metastasis, curative resection can be done 
when there is no extra hepatic involvement and it is possible to resect 
the disease in liver.  
Diagnostic laproscopy can detect any liver mets, any extra hepatic 
involvement and thereby reducing the unnecessary laprotomies. SL  
may decrease the duration of hospital stay , cost of treatment and early 
adjuvant theraphy when compared to open laprotomies. 
The benefit of SL can be assessed with Clinical Risk Score (CRS)  
System .It includes five criteria and each carries one point. 
1. Lymph node positive colon cancers 
2. Disease free interval less than 12 months 
3. More than one hepatic tumour 
4. Size of largest hepatic tumour greater than 5 cm 
5. CEA greater than 200 ng/ml within one month of surgery 
The yield of SL is higher if CRS>2 
In patients with colorectal cancers with hepatic metastasis staging 
laproscopy can be safely performed. The cost and duration of treatment 
can be reduced if early curative  laprotomy and resection  is done when 
SL is negative for metastatic disease. 
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MATERIALS AND METHODS 
AIMS & OBJECTIVES: 
Diagnostic laparoscopy helps in diagnosing and staging 
Gastrointestinal (GI) cancers. Routine laparoscopy before laparotomy, 
especially in cancers that have equivocal operability, helps to avoid 
unnecessary laparotomies.  
Present study evaluates utility of laparoscopy in diagnosing and 
staging GI cancers. 
PLACE OF STUDY: 
DEPARTMENT OF GENERAL SURGERY, STANLEY 
MEDICAL COLLEGE AND HOSPITAL 
DURATION: 
JAN 2013 TO DEC 2013 
STUDY DESIGN: 
PROSPECTIVE  STUDY 
PATIENT SELECTION: 
Patients who have been clinically and radiologically diagnosed as 
gastrointestinal malignancies  
EXCLUSION CRITERIA: 
1. Patient not willing to get the investigations done 
2. Patient who  are not fit for performing laproscopy 
3. Hemodyanamic instability 
4. Uncorrected coagulopathy 
5. Multiple previous abdominal procedures 
METHODOLOGY: 
Patients admitted in our hospital with clinical diagnosis from  jan 
2013 to  2013 dec 2013 will be enrolled in our study. 
A detailed history taking  followed by full clinical examination 
and basic blood investigations 
Patients are subjected to  ultrasonogram and cectand biopsy 
proven malignancy in  department  .  
Findings interpreted, patients subjected to surgery based on 
clinical scenario 
This study contains 30 patients, 13 males and 17 females. A 
detailed history of patient was taken. The hospital records were 
reviewed to obtain information regarding age, sex, occupation, date of 
admission and discharge, operative date and clinical investigation 
Diagnostic Laparoscopy was performed and details were noted. 
According to the observations in SL patients were subjected to further 
course of management. Patients were also followed to known 
complications, convalescence & hospital cost. 
Examination 
All patients with abdominal malignancies were examined 
thoroughly and the findings were recorded. 
In all patients with abdominal malignancies complete general 
physical examination, local examination and systemic examination was 
done. All these were examined by inspection, palpation, percussion and 
auscultation. 
Investigations: 
In patients with abdominal malignancies we undertook following 
investigations as required : 
Haemotological – Hb%, TC, DC, ESR. 
Biochemical - RBS, Blood urea, Serum creatinine, Serum 
electrolytes, LFT Radiological – Chest X- ray, X-ray erect 
abdomen, ultrasound abdomen and pelvis,  Upper  GI  endoscopy,  
lower  GI  endoscopy  and  CT  scan wherever applicable. 
Laparoscopy 
After complete workup and investigations clinical diagnosis 
ascertained, radiological help obtained wherever possible and patients 
were considered for diagnostic laparoscopy. All patients were informed 
of the risks and benefits of the procedure and also explained about the 
probability of laparotomy if need arose and for the definitive procedure 
when required.  
After creating the pneumoperitoneum using veress needle or blind 
trocar insertion method 10 mm telescope was placed through the supra / 
subumbilical port, another 5 mm port was placed in the upper or lower 
abdomen to allow manipulation or biopsy of intraabdominal pathology. 
A thorough evaluation of peritoneal cavity, was made and 
wherever required biopsy was taken. Subsequently thorough staging was 
done wherever feasible a therapeutic procedure was also performed by 
laparoscopy. 
If the condition did not require any intervention nothing else was 
done. 
The operative time represented the total time is in minutes from 
insertion of the first trocar insertion to completion of staging procedure. 
Convalescence period was determined from day of surgery to discharge 
or expiry. Complications were determined intraoperatively and post 
operatively, morbidity in respect to wound sepsis (surgical site 
infection), respiratory distress etc. 
Mortality if any, were recorded. 
 
 
 
 
 
 
 
 
 
 
STATISTICAL METHODS APPLIED 
Descriptives 
The Descriptives procedure displays univariate summary statistics 
for several variables in a single table and calculates standardized values 
(z scores). Variables can be ordered by the size of their means (in 
ascending or descending order), alphabetically, or by the order in which 
you select the variables (the default). 
Frequencies 
The Frequencies procedure provides statistics and graphical 
displays that are useful for describing many types of variables. For a 
first look at your data, the Frequencies procedure is a good place to start. 
Crosstabs 
The Crosstabs procedure forms two-way and multiway tables and 
provides a variety of tests and measures of association for two-way 
tables. The structure of the table and whether categories are ordered 
determine what test or measure to use. 
 
Independent-Samples T Test 
The Independent-Samples T Test procedure compares means for 
two groups of cases. Ideally, for this test, the subjects should be 
randomly assigned to two groups, so that any difference in response is 
due to the treatment (or lack of treatment) and not to other factors. 
One sample T test 
The  One Sample T Test procedure tests whether the mean of a 
single variable differs from a specified constant. 
All the statistical methods were carried out through the SPSS for 
Windows (version16.0). 
 
 
 
 
 
 
 RESULTS 
During 1 years of study period from January2013 to December 2013 a 
total of 30 new cases of abdominal malignancies underwent Diagnostic 
laparoscopy after thorough clinical evaluation and appropriate 
radiological & histological investigations. 
TABLE 1. AGE  & SEX DISTRIBUTION 
Age group 
in years 
Male 
 
Female 
 
Total 
 
Percentage 
% 
21-30 1 2 3 10 
31-40 1 2 3 10 
41-50 2 5 7 23.3 
51-60 5 1 6 20 
61-70 4 7 11 36.7 
Total 13 17 30 100 
 
CC= 0.378; P= 0.288 (NS) 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
GRAPH 1. AGE DISTRIBUTION  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
The age group with maximum number of cases was the 61-70 age 
group followed by 41-50 age group and then by 51-60 age group. Mean 
age for group being 53years 
There were 13 Male & 17 Female patients in the study which is 
comparable. 
 
 
 
 GRAPH 2. SEX WISE DISTRIBUTION  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The youngest male patient was of 21 years & the oldest 70 years 
of age, the mean age of male patients being 53.4 years. 
The youngest female patient was of 26 years & the oldest 70 
years of age, the mean age of female patients being 52.6 years. 
 
 
 
 
TABLE 2. DISTRIBUTION OF CASES ACCORDING TO 
TUMOUR SITE 
 
Tumour site No. of Patients Percent 
Colorectal 13 43.3% 
Stomach 15 50.0% 
Gall Bladder 2 6.7% 
 
 
 
GRAPH 3.  TUMOUR SITE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stomach malignancies constituted 15 (50%) cases of the study 
cases followed by Colorectal which constituted 13(43%) and rest by 
Gall bladder malignancies 2(7%) cases of the study. 
 
 TABLE 3. RESECTABILITY ACCORDING TO THE TUMOUR 
SITE 
 
 
SITE 
TOTA
L COLORECTA
L 
STOMAC
H 
GALL 
BLADDE
R 
 
RESECTABLE 12  (92.3%) 
 
5 (33.3%) 
 
0 (0%) 
 
17 
(56.7%
) 
UNRESECTAB
LE 
1 (7.7%) 
 
10 (66.7%) 
 
2 (100%) 
 
13 
(43.3%
) 
TOTAL 13 152  30 
 
CC= 0.545; P= 0.002 (S) 
 
GRAPH 4. RESECTABILITY ACCORDING TO TUMOUR SITE 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There were 2 cases of Gall bladder malignancies and both of them 
were unresectable. 
There were 15 cases of Stomach malignancies out of which 10 
(66.7%) were unresectable. Out of 13 cases of colorectal malignancies 
only 1(7.7%) was found to be unresectable. 
Table 4. LYMPH NODE STATUS ON STAGING 
LAPAROSCOPY   
 
   
site 
Colorectal  Stomach   Gall bladder   Total 
LYMPH  N0  Count  1  0  0  1 
  %  SITE  7.7% 0% 0% 3.3% 
 N1 Count  7% 6 2 15 
  %  SITE  53.8%   40.0% 100.0% 50.0% 
 N2 Count  5 9% 0 14 
  %  SITE  38.5% 60.0% 0% 46.7% 
 N3 Count  13 15 2 30 
  %  SITE  100% 100.0% 100.0% 100.0% 
CC= 0.545; P= 0.002 (S) 
 
GRAPH 5. LYMPH NODE STATUS ON STAGING 
LAPAROSCOPY 
   
 
 
 
 
 
In half of the cases there were N1 level lymph nodes and 14 
cases(46.7%) having N2 level lymph nodes. Only 1 case had N0 lymph 
node status seen in colorectal malignancy. 
 
Table 5. LIVER METASTASES ON STAGING LAPAROSCOPY 
 
   
site 
Colorectal  Stomach   Gall bladder   Total 
LYMPH  N0  Count  12  11 1 24 
  
%  
within 
SITE   
92.3% 73.3% 50.0% 80.0% 
 N1 Count  1% 4 1 6 
  
%  
within 
SITE   
7.7%   26.7% 50.0% 20.0% 
 N2 Count  13 15 2 30 
  
%  
within 
SITE   
100% 100.0% 100.0% 100.0% 
CC= 0.291;  P= 0.250 (NS) 
 
GRAPH 6. LIVER METASTASES ON STAGING 
LAPAROSCOPY 
 
 
 
Only 6 cases(20.0%) had liver metastases found on staging 
laparoscopy. Out of 6 cases, 4 cases were from stomach malignancy and 
only 1 each from colorectal & gall bladder malignancy. 
Rest 24 cases had no hepatic metastases on staging laparoscopy. 
Table 6. LYMPH NODE STATUS ON STAGING 
LAPAROSCOPY   
 
   
site 
Colorectal  Stomach   Gall bladder   Total 
PERITO Negative Count  12  9 1 22 
  
%  
within 
SITE   
92.3% 60.0% 50.0% 73.3% 
 Positive Count 1 6 1 8 
  
%  
within 
SITE   
7.7%   40.0% 50.0% 26.7% 
Total  Count  13 15 2 30 
  
%  
within 
SITE   
100.0% 100.0% 100.0% 100.0% 
 
CC= 0.545; P= 0.002 (S) 
 
GRAPH 7. PERITONEAL NODULES ON STAGING 
LAPAROSCOPY 
 
   
 
 
 
 
Totally out of 30 cases, 8 cases (26.7%) had peritoneal nodules on 
staging laparoscopy. Most no. of cases were from stomach constituting 
6 cases and other cases were from colorectal & gall bladder which 
constituted 1 each. 
 
Table 7. OMENTAL NODULES ON STAGING LAPOROSCOPY  
 
   
site 
Colorectal  Stomach   Gall bladder   Total 
PERITO Negative Count  13 6 0 19 
  
%  
within 
SITE   
100.0% 40.0% 0% 63.3% 
 Positive Count 0 9 2 11 
  
%  
within 
SITE   
0% 60.0% 100.0% 36.7% 
Total  Count  13 15 2 30 
  
%  
within 
SITE   
100.0% 100.0% 100.0% 100.0% 
 
CC= 0.579; P= 0.004 (S) 
 
GRAPH 8. OMENTAL NODULES ON STAGING 
LAPAROSCOPY 
 
 
 
   
 
 
 
Omental nodules are seen in 11 (36.7%) cases out of total 30. 
Stomach malignancies resulted in 9 (60.0%) cases of omental 
malignancies out of 15 cases. Both the cases of Gall bladder 
malignancies had omental nodules. 
No cases of colorectal malignancies had omental nodules. 
 
Table 8. ASCITES ON STAGING LAPAROSCOPY 
 
   
site 
Colorectal  Stomach   Gall bladder   Total 
ASCITIC Negative Count  10 8 1 19 
  
%  
within 
SITE   
76.9% 53.3% 50.0% 63.3% 
 Positive Count 3 7 1 11 
  
%  
within 
SITE   
23.1% 46.7% 50.0% 36.7% 
Total  Count  13 15 2 30 
  
%  
within 
SITE   
100.0% 100.0% 100.0% 100.0% 
 
CC= 0.240; P= 0.400 (NS) 
 
ASCITES ON STAGING LAPAROSCOPY 
 
 
Ascites was present in 11 (36.7%) case while absent in 19 
(63.3%) cases. 7 out of 15 cases of stomach malignancies had ascertic 
on staging laparscopy while only 3 out of 13 cases of colorectal 
malignancies had ascites present. 
1 out of 2 patients of Gall bladder malignancies had ascites. 
 
Table 9. MENSENTRIC NODULES ON STAGING 
LAPAROSCOPY 
 
   
site 
Colorectal  Stomach  Gall bladder   Total 
MESENTRIC Negative Count  13 13 2 28 
  
%  within 
SITE   100% 86.7% 100.0% 93.3% 
 Positive Count 0 2 0 2 
  
%  within 
SITE   0% 13.3% 0% 6.7% 
Total  Count  13 15 2 30 
  
%  within 
SITE   100% 100.0% 100.0% 100.0% 
 
CC= 0.258; P= 0.343 (NS) 
 
GRAPH 10.  MESENTRIC NODULES ON STAGING 
LAPAROSCOPY 
 
 
 
   
 
 
 
 
Only 2 (6.7%) cases had mesenteric nodule on staging 
laparoscopy and both the cases had stomach malignancies. No cases of 
Colorectal or Gall bladder malignancy had mesentric nodules on staging 
laparoscopy. 
Table 10. PELVIC METASTASES ON STAGING 
LAPAROSCOPY 
 
   
site 
Colorectal  Stomach   Gall bladder   Total 
MESENTRIC Negative Count  11 14 2 27 
  
%  within 
SITE   84.6% 93.3% 100.0% 90.0% 
 Positive Count 2 1 0 3 
  
%  within 
SITE   15.4% 6.7% 0% 10.0% 
Total  Count  13 15 2 30 
  
%  within 
SITE   100.0% 100.0% 100.0% 100.0% 
 
CC= 0.164 ;  P= 0.662 (NS) 
 
PELVIC METASTASES ON STAGING LAPAROSCOPY 
 
Pelvic metastases were found in only 3 (10%) cases and rest of 
the cases it was normal. 
2 cases of colorectal malignancy had pelvic metastases. 
1 case of stomach malignancy had bilateral ovarian secondaries 
(Krukenberg’s tomour) found at staging laparoscopy. No pelvic 
metastases seen in gall bladder malignancies. 
 
 
 
Table 11. RESECTABILITY ACC TO ENDOSCOPIC SITE OF 
TUMOUR 
 
 ENDOSCOPIC SITES Total 
Fundus Body Pylorus Caecum Splenic 
flexure 
Upper 
rectum 
Middle 
rectum 
Lower 
rectum 
Laparosopi  
R 
1 3 1 2 1 3 2 4 17 
C Staging          
 50.0% 30.0% 33.3% 100.0% 100.0% 100.0% 100.0% 80.0% 60.7% 
U 1 7 2 0 0 0 0 1 11 
 50.0% 70.0% 66.7% 0% 0% 0% 0% 20.0% 39.3% 
Total 2 10 3 2 1 3 2 5 28 
 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
 
CC= 0.530;  P= 0.141 (NS) 
 
GRAPH 12.  RESECTABILITY ACCORDING TO ENDOSCOPIC 
SITE OF TUMOUR 
 
 
 
   
 
 
Tumours were subdivided according to endoscopic sites. It was done only in 28 
cases excluding  2 cases of Gall bladder malignancy. 
Out of total 15 cases of stomach malignancy - 10 cases had tumour in Body, 3 in 
pylorus & 2 in fundus of stomach. Totally there were 10 unresectable cases of 
stomach malignancy out of which 7 cases were in Body, 2 in pylorus & 1 case in 
fundus of stomach. 
Out of total 13 cases of colorectal malignancy – 10 cases were in Rectum, 2 in 
Caecum and 1 case had tumour in splenic flexure. Further subdividing rectal tumour 
there were 5 cases in lower 1/3 , 3 in upper 1/3 and 2 were in middle 1/3 . Only 1 
case of colorectal malignancy was unresectable which was in lower rectum.   
 
 
Table 12. LAPAROTOMY STAGING ACC. TO ENDOSCOPIC 
SITE OF TUMOUR 
 
 ENDOSCOPIC SITES Total 
Fundus Body Pylorus Caecum Splenic 
flexure 
Upper 
rectum 
Middle 
rectum 
Lower 
rectum 
Laparotomy R 1 2 1 2 1 3 2 2 14 
C Staging          
 50.0% 20.0% 33.3% 100.0% 100.0% 100.0% 100.0% 60.0% 50.0% 
U 1 5 2 0 0 0 0 0 8 
 50.0% 50.0% 66.7% 0% 0% 0% 0% 0% 28.6% 
N 0 3 0 0 0 0 0 3 6 
A 0% 30.0% 0% 0% 0% 0% 0% 40.0% 22.4% 
Total 2 10 3 2 1 3 2 5 28 
 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
 
CC= 0.620;  P= 0.229 (NS) 
 
GRAPH 13.  LAPAROTOMY STAGING ACC. TO ENDOSCOPIC 
SITE OF TUMOUR 
 
 
   
 
 
 
 
 
 
Totally there were 28 cases out of which 6 cases did not undergo laparotomy – 3 
cases of stomach body tumour which were unresectable & 2 cases of lower rectal 
tumour which were resected laparoscopically & 1 case of lower rectal 
malignancy was found unresectable 
There were 14 resectable cases on laparotomy and 8 cases were found to be 
unresectable on staging laparoscopy. 
 Table 13. TYPE OF SURGERY PERFORMED 
 LAPARSCOPIC STAGE   
PROCEDURE RESECTABLE UNRESECTABLE TOTAL PERCENT 
DEFINITIVE 16(94.1%) 0(0%) 16 53.3% 
PALLIATIVE 1 (5.9%) 6(46.2%) 7 23.4% 
COLOSTOMY 0(0%) 1 (7.6%) 1 3.3% 
BIOPSY 0(0%) 6(46.2%) 6 20.0% 
TOTAL 17(100.0%) 13(100.0%) 30 100.0% 
 
CC= 0.685;  P= 0.000 (S) 
 
GRAPH 13.  LAPAROTOMY STAGING ACC. TO ENDOSCOPIC 
SITE OF TUMOUR 
 
 
   
 
 
 
 
 
17 cases were found to resectable on Laparoscopic staging but only 16 
underwent definitive procedure as 1 case of stomach body tumour was found 
to be unresectable on laparotomy and underwent only palliative procedure. 
Totally 7 cases underwent Palliative procedure, 1 patient underwent 
colostomy and rest of 6 unresectable case undergone only laparoscopic biopsy 
for tissue diagnosis. 
Thus 13(43.3%) cases out of 30 were prevented from undergoing 
unnecessary exploratory laparotomy 
Table 14. DURATION OF STAGING LAPAROSCOPY 
 LAPSTAGE N Mean Std. Deviation 
DURNLAP R 17 17.3529 3.99908 
 U 13 20.7692 5.71772 
 
 
    t-test for Equality of Means 
  t df Sig.(2-tailed) Mean 
Difference 
DURNLAP Equal 
variances 
assumed 
-1.927 28 .064 -3.4163 
 
 
Mean duration of Staging laparoscopy was 18.83 minutes. 
Staging laparoscopy mean duration in resectable group was found to be 
17.35 mins which was found to be lower than mean duration in unresectable 
group was 20.76mins. 
Unresectable group had higher mean duration for staging laparoscopy 
as 6 cases required laparoscopic biopsy as only procedure. 
Difference between the mean duration for resectable & unresectable 
groups was not found to be statistically significant (P value = 0.064) 
 
 
 
 
 
 
 
 
 
 
 Table 15. COMPLICATIONS OF STAGING LAPAROSCOPY 
 No. of Patients Percent 
Complications 5  16.7% 
No. complication 25 83.3% 
Total 30 100.0%   
 
Chi square value = 13.333 ; P=0.000 (S) 
 
GRAPH 16. COMPLICATIONS OF STAGING LAPAROSCOPY 
 
 
   
 
 
 
 
 
 
 
There were No complications in 25(83.7%) cases and only 5(16.7%) 
cases had complications. 3(10.0% )cases had minor complication of operative 
wound sepsis. 
Only 2 (6.7%) cases had major respiratory complication. 
There  was No Mortality in the 30 study cases 
Table 16. CONVALESCENCE PERIOD OF PATIENTS 
 
 LAPSTAGE N Mean Std. Deviation Std. Error Mean 
CONVAL R 17 10.5882 2.80755 .68093 
 U 13 5.0000 1.73205 .48038 
 
  t-test for Equality of Means 
  T Dt Sig. (2- tailed) Mean 
Difference 
CONVAL Equal 
variances 
assumed 
6.303 28 .000 5.5882 
 
Mean Convalescence period for the study group is 8.2days 
Mean Convalescence period for Unresectable patients was found to be 
5 days which was found to be significantly lower than Resectable group 
which was 10.58 days. 
 
 
 
 
 
 
 
 
 Table 17. COST EFFECTIVENESS 
 
 LAPSTAGE N Mean Std. Deviation Std. Error Mean 
COST R 17 10388.235 2071.3054 502.36535 
 U 13 7785.3846 3053.0384 846.76051 
 
 
 t-test for Equality of Means 
  T dt Sig. (2- tailed) Mean 
Difference 
COST Equal 
variances 
assumed 
2.782 28 .010 2602.8507 
 
Mean cost for study group was Rs.8897 
Mean cost for Unresectable group was Rs.7785 which was found to be 
significantly lower than Resectable group having mean cost of Rs.10388 
(P=0.01). 
 
 
 
 
 
 
Table 18. EFFECT OF COMPLICATIONS ON 
CONVALESCENCE & COST EFFECTIVENESS 
 
 COMPLI N Mean Std. Deviation Std. Error Mean 
CONVAL Y 5 10.8000 3.83406 1.71464 
 N 25 7.6400 3.48664 .69733 
COST Y 5 12630.000 2896.12672 1295.187 
 N 25 8586.4000 2315.95216 463.1904 
 
 t-test for Equality of Means 
 T dt Sig. (2- tailed) Mean Difference 
CONVAL 1.823 28 .079 3.1600 
COST 3.429 28 .002 4043.6000 
 
GRAPH 19. EFFECT OF COMPLICATIONS ON 
CONVALESCENCE 
 
 
 
 
 
GRAPH 20. EFFECT OF COMPLICATIONS ON COST 
EFFECTIVENESS 
 
 
   
 
 
 
 
 
 
 
Convalescence period for patient having complications was higher than 
patients without complication (10.8 vs 7.6days) which was not found to be 
statistically significant. 
Cost for patient having complications was also higher than patients 
without complication (12630 vs 8586) which was found to be statistically 
significant. 
 
 
 
 
 
 
 Table 19. CONVALESCENCE OF STUDY GROUP VS 
LAPAROTOMY & CLOSURE IN HOSPITAL 
 
 N Mean Std. Deviation Std. Error Mean 
CONVAL 13 5.0000 1.73205 .48038 
 Test Value = 8 
 T Df Sig. (2-tailed) Mean Difference 
CONVAL -6.245 12 .000 -3.0000 
 
Table 20. COST EFFECTIVENESS OF STUDY GROUP VS 
LAPAROTOMY & CLOSURE IN HOSPITAL 
 
 N Mean Std. Deviation Std. Error Mean 
CONVAL 13 7785.3846 3053.03842 846.76051 
 Test Value = 10000 
 T df Sig. (2-tailed) Mean Difference 
CONVAL -2.615 12 .023 -2214.6154 
 
 
 
 
 
Table 22. COST EFFECTIVENESS OF STUDY GROUP VS 
LAPAROTOMY & CLOSURE IN HOSPITAL 
 
 
 
 
 
 
Mean Convalescence period and Cost for Unresectable group was 
compared for laparoscopic group & laparotomy and closure group in our 
hospital. 
Mean Convalescence period for laparoscopic group was found to be 
very significantly lower compared to laparotomy group in our hospital (5 vs 
8days; P value= 0.000) 
Mean Cost for laparoscopic group was also found to be significantly 
lower compared to laparotomy group in our hospital (7785 vs 10,000; P value 
= 0.023). 
 
 
 
 
 
 
DISCUSSION 
Our aim of the study is to study the role of diagnostic laparoscopy 
for staging in abdominal malignancies. 
In our study 30 cases of abdominal malignancies admitted in 
Stanley Medical College Hospital during the study period i.e. JAN 2013 
to DEC 2013 were included 
Diagnostic laparoscopy was performed in each patient 
immediately before the planned elective surgery. It resulted in change in 
further course of management of significant number of patients and was 
associated with less morbidity. 
Age and sex incidence: 
Out of 30 cases studied 13 were male patients and 17 were female 
patients constituting 43.3% and 56.7% respectively. 
Patients ranged from 21 years to 70 years with mean age being 53 
years. 
Maximum number of patients in our study were in age group 61-
70 followed by 41-50 and 51 – 60 years. Abdominal malignancies show 
increasing trend with age. It  is similar to that seen in other studies. 
Ozmen MM et al study comprised 48 patients ranging from 26 – 72 
years (mean 54.5) with 26 males and 22 females. Hemming AW et al 
study comprised 162 patients with patients ranging from 28 to89 years 
(mean 67 years) and male to female ratio of 3:2. Lehnert T et al study 
comprised 120 patients  ranging from 30 – 84 years (mean 65 years) 
with 78 males &42 females. 
Age group studied was found to be in accordance to other studies. 
Tumour site : 
Study group had 30 cases comprising 15 (50.0%) cases of 
stomach tumour, 13 (43.3%) cases of colorectal & 2 (6.7%) cases of 
biliary tract  tumours. 
Muntean V et al study comprised 119 cases with 6 primary 
locations studied. Stomach tumours were 45 ( 37.8%), 20 (16.8%)cases 
of colon tumour and only 4 cases of biliary tract tumours. 
Liver Metastases: 
Liver metastases was found in 6 (20%) of cases while 24 cases 
had no liver involvement on Staging Laparoscopy. Lehnert T et al had 
3(20%) patients with liver metastases out of 15 patients undergoing 
staging laparoscopy precluding liver metastases out of 15 patients 
undergoing staging laparoscopy precluding study revealed liver 
metastases in 12(12.12%) patients out of 99 patients. But 18 out of 20 
cases of colon tumour had liver metastases with 2 of them being 
unresectable. Ozmen MM et al study showed liver metastases in 
18(33.3%) cases out of total 48 patients. 
Thus in various studies, Liver metastases on diagnostic 
laparoscopy are found in about 12 – 33% of cases. It was seen in 20% of 
cases in our study, which was found to be similar to other similar 
studies. 
Peritoneal nodules : 
Peritoneal nodules were found in 8 (26.7%) cases in our study. 
Mostly they were seen in patients with stomach malignancies. Only 1 
case of colorectal malignancy & 1 case of gall bladder malignancy had 
peritoneal nodules. Muntean V study revealed peritoneal seeding in 32 
(32.3%) cases & in 1 case of colon malignancy out of 20cases. Ozmen 
MM et al study on gastric cancer revealed peritoneal seeding in 8 cases 
(16,6%) out of 48. 
Thus previous studies have revealed Peritoneal seeding in 16 – 
32% cases. In our study it was found to be in 26.7% cases which were in 
accordance to the other studies. These peritoneal nodules were missed 
on CT scan & other imaging modalities. Staging laparoscopy was found 
to be most sensitive modality for peritoneal seedlings. 
Ascites : 
In our study Ascitic fluid was found in 11(36.7%) cases. Ascitic 
fluid was aspirated in each case and sent for cytological analysis. No 
irrigation cytology was done in this study. Most of the case had free 
fluid evident on pre operative imaging modality had negative cytology 
on Ascitic fluid analysis pre operatively. Ozmen MM had positive 
peritoneal cytology in 11 cases out of 48 (22.9%). 
Our study results are not comparable to other studies as peritoneal 
cytology was not routinely performed procedure. It was not done if no 
ascitic fluid was found on staging laparoscopy. 
Omental , Mesentric & Pelvic nodules: 
Omental nodules were found in 11 cases in our study. All cases 
were of Upper Gastrointestinal malignancies – 9 stomach & 2 gall 
bladder. No colorectal malignancies resulted in omental nodules. 
Mesentric & Pelvic Nodules are not found commonly and were 
reported in only 2 & 3 cases respectively in our study. Pelvic nodules 
were seen in 2 cases of colorectal malignancy. 1 case of stomach tumour 
had Secondaries on bilateral ovaries found on staging laparoscopy. 
Mesentric nodules were seen in 2 cases of stomach tumours 
1 case of stomach tumour was found to have splenic nodule. 
Lymph Node status: 
Lymph nodes were found to be involved by lymphatic spread 
from tumour which is seen quite early in tumour spread. In our study 
lymph nodal metastases was found in 29 out of 30 patients. It does not 
prevent curative resection unless extensive involvement (N3 status). 
Even in such cases palliative resection is possible, so lymph node 
staging as independent predictor does not have much impact in changing 
management & preventing exploratory laparotomies. 
Resectability According to Tumour site: 
On staging laparoscopy, in our study 17 cases were deemed 
Resectable & 13 cases as Unresectable. In our study 43.3% cases were 
found to be Unresectable on Staging Laparoscopy. These patients were 
prevented from undergoing unnecessary exploratory laparotomy. 
Muntean V et al in his study had 36 (36.4%) patients avoided from 
undergoing unnecessary laparotomies. Hemming AW et al in their study 
feel that laparoscopic staging in intraabdominal malignancies is of value 
& will prevent upto 36% of futile laparotomies. 
43.3% patients in our study were prevented from unnecessary 
laparotomy which was higher than seen in other studies probably as the 
patients in our study group are not very well educated and present in the 
later stage of disease compared to Western population. Most of the 
patient found to be Unresectable did not had severe obstructive 
symptoms and thus present later in the disease stage. 
Further subdivision according to tumour site revealed 10 cases of 
stomach malignancies to be unresectable out of total 15 cases(66.66%). 
Further they were analysed according to endoscopic site of tumour 
which revealed 7 out of 10 cases from body of stomach. Tumour in 
body of stomach present in later stages of disease as patient does not 
develop prominent obstructive symptoms seen in fundic or pyloric 
tumours. 2 cases of pyloric tumour & 1 fundic tumour were found to be 
unresectable. 
Muntean V et al found in his study 26 cases of stomach cancers to 
be unresectable on Staging laparoscopy out of total 45 cases(57.77%). 
Asencio F et al did study on gastric adenocarcinoma & found that 
despite apparently extensive preoperative assessment, laparotomy was 
abandoned in 41% of patients after laparoscopic staging. 
In our study 66.66% of stomach tumour were found to be 
unresectable which was higher compared to other studies probably 
because body of the stomach constituted major part of all the stomach 
tumours. 
In our study there were 13 cases of colorectal malignancies which 
on further subdivision into Caecum 2, Splenic flexure 1, Upper rectum 
3, Middle rectum 2 & lower rectum 5 cases. Only 1(7.7%) case of lower 
rectal tumour was found to be unresectable on Staging Laparoscopy. 
Muntean V et al found in his study that 4 cases(20%) to be unresectable. 
Grobmyer SR et al in their study on Diagnostic laparoscopy prior to 
planned hepatic resection for colorectal metastases found in their study 
that staging laparoscopy prevented nontherapeutic celiotomy in 10% of 
patients. 
In our study only Laparoscopy was used for imaging liver 
metastases from colorectal malignancies and no use of LUS was made 
resulting in lower detection of hepatic metastases. 
Only 2 cases of extrabiliary tumour were present in our study 
which were both found to be unresectable on Staging Laparoscopy and 
thus avoided unnecessary laparotomy. Muntean V et al found 2 cases 
out of 4(50%) to be unresectable in the study which were found to have 
extensive spread on Staging Laparoscopy. 
There are few series evaluating the use of laparoscopy in patients 
with gallbladder cancer. Although the yield of laparoscopy was up to 
80% in some studies, the patients evaluated had minimal preoperative 
imaging, often with ultrasound alone, and laparoscopy was used 
primarily as a diagnostic tool. Results found in our study had only 2 
patients which are too low to draw conclusions.  
Total 17 cases were found to be resectable on Staging 
Laparoscopy out of which 16(94%) cases underwent definitive 
procedure. 1 case (6%) was found to be unresectable on laparotomy 
which was not found on Staging Laparoscopy due to infiltration into the 
pancreas. 
1 case of unresectable colorectal tumour underwent colostomy & 
other 7 unresectable cases underwent palliative procedure.  
6 cases underwent only laparoscopic biopsy as only procedure 
after staging laparoscopy. 
 
Duration of Staging Laparoscopy : 
Mean duration of Staging Laparoscopy was 18.83 min (10-
30mins). It was little higher in unresectable group compared to 
resectable (20 vs 17mins respectively) which was not found to be 
significantly different. Muntean V et al in their study had 48 mins mean 
operative time for SL (25-90mins.) In this study extended staging 
laparoscopy, peritoneal lavage, LUS including colour doppler was done 
resulting in more mean time for SL. 
Complications : 
Procedure related complications were seen in 5 cases in our study 
out of which4 cases were resectable – 2 major & 2 minor complications. 
Only 1 case of unresectable group had minor wound sepsis. 
There was no mortality in the study group. 
Convalescence Period: 
Mean convalescence period was 8.2 days (2-16days) in the study. 
It was found to be significantly less in unresectable group compared to 
patients undergoing definitive surgery. (P = 0.000) 
Convalescence period in patients with complications was 10.8 
days compared to 7.6 days in patients without complications, which was 
not found to be significantly higher. 
Convalescence period was very significantly low in patients 
undergoing SL compared to exploratory laparotomy & closure ( 5 vs 8 
days respectively; P = 0.000) when it is the only procedure required. 
Similar evidence is found in various studies. In his study Muntean V et 
al average length of stay after SL compares favourably with open 
exploration. 
Cost effectiveness : 
Mean cost for study group was Rs 8,897 (4,665 – 16,150). Cost 
for Unresectable group was significantly lower compared to resectable 
group ( P = 0.01). 
Cost in patients having complications following surgery was also 
found to be significantly higher compared to other group without 
complications ( P = 0.002). 
Cost effectiveness of staging laparoscopy, compared to open 
procedure was also found to be significantly lower (P=0.023) when 
performed as the only procedure for the patient. In similar study done by 
Muntean V et al when done as only procedure SL resulted in 55 -60% 
reduction in total hospital charges. 
CONCLUSION 
Staging laparoscopy has a very significant role in abdominal 
malignancies. It is very accurate in assessing peritoneal seeding, hepatic 
metastases which are not found on imaging modalities. 
A short SL performed just before the planned surgical procedure 
to certify the operability is found to be safe & very effective and need 
not be performed as a separate procedure. But short SL is less sensitive 
in staging compared to extended SL and use of LUS 
Staging Laparoscopy is found to be more useful in staging gastric 
& extra hepatic biliary tumour when compared to colorectal cancers. 
Staging Laparoscopy gives additional information regarding 
extent of the disease intra-abdominally which changes the course of 
management in significant number of patients. Staging laparoscopy had 
a significant impact on decisions regarding the treatment plan in 
patients. It helps in more careful planning of palliative& resectional 
procedure in advanced conditions. 
Staging Laparoscopy has added benefit of performing biopsy 
from sites of dissemination & having histological confirmation. 
Staging Laparoscopy spares malignancy patients from 
unnecessary laparotomies. 
Staging Laparoscopy has been found to significantly decrease the 
hospital stay & cost expenditure when compared to open exploration. 
Limitation of the study was it has small sample size comprising 
only stomach, gall bladder & colorectal malignancies. Evaluation of 
lesser sac & pancreatic infiltration was not possible & peritoneal 
cytology was not done in all cases. 
Staging  laparoscopy should be a routine tool in the 
armamentarium of all surgeons performing surgeries routinely on 
abdominal malignancies. It should be used as a diagnostic tool 
comprehending other imaging modalities. 
 
 
 
 
 
 
SUMMARY 
 The present study entitled “Role of diagnostic laparoscopy for 
staging in abdominal malignancies” was undertaken at 
STANLEY. Medical College and Hospital from January 2013 to 
December 2013. 
 Staging Laparoscopy was performed in 30 patients (100%). 
 Laparoscopy could accomplish proper staging in 29 cases (96.7%) 
i.e. the sensitivity of SL is 0.97 and specificity of test being 1. 
 Unnecessary and futile laparotomies were avoided in 13 patients 
(43.3%). 
 Only 1 patient (3.3%) had to be subjected to laparotomy 
following SL and found to be unresectable. 
 Average duration of laparoscopic surgery was 18.8 minutes. 
 Average hospital stay was 8.3 days. It was significantly lower in 
SL compared to open exploration. 
 Mean Hospital cost was Rs. 8,897. SL is cost effective compared 
to open exploration. 
 Morbidity & mortality are found to be very low in patients 
undergoing only Staging laparoscopy. 
 SL was associated with decreased morbidity & pain, faster 
recovery & quicker initiation of adjuvant therapies. 
  
                                                            MASTER  CHART 
  
Sl.No Name IP No Age Sex Diagnosis 1 2 3 4 5 
1 Ponnusamy 45281 65 M CA STOMACH + - - 
 
+ - 
2 Ramesh 24678 68 M CA STOMACH - + 
 
- + - 
3 Appavu 53772 62 M COLORECTAL  CA - - - - + 
4 Ibrahim 23527 64 M COLORECTAL  CA - - - - + 
5 Kannan 42726 53 M CA STOMACH - - - - + 
6 Mohamed salim 32527 55 M CA STOMACH - - - - + 
7 Kuppusamy 32671 58 M CA STOMACH - - + + - 
8 Karna 42672 56 M CA GALLBLADDER - + - + - 
9 Joseph 42621 51 M COLORECTAL  CA - - - - + 
10 Krishnan 42622 46 M COLORECTAL  CA - - - - + 
11 Syed Ali 42626 44 M COLORECTAL  CA - - - - + 
12 Babu 53227 35 M CA STOMACH - + + + - 
13 Suleman 32521 29 M COLORECTAL  CA - - - - + 
14 Munniyammal 32525 62 F COLORECTAL  CA - - - - + 
Sl 
No 
Name Ip No Age Sex Diagnosis 1 2 3 4 5 
15 Prathunisha 23251 64 F COLORECTAL  CA + - + + - 
16 Dawath Bee 32425 63 F CA STOMACH - + - + - 
17 Valliyammal 32252 68 F CA STOMACH + + + - - 
18 Mallarkodi 23245 70 F CA STOMACH + + - + - 
19 Chandra 24522 69 F CA GALLBLADDER + + - + - 
20 Palaniyammal 32522 61 F COLORECTAL  CA - - - - + 
21 Rukumani 25253 55 F COLORECTAL  CA - - - - + 
22 Kalayarasi 34252 43 F COLORECTAL  CA - - - - +  
23 Jansirani 23352 45 F CA STOMACH - - - - + 
24 Dhanam 23252 47 F CA STOMACH - - - - + 
25 Angammal 23526 48 F CA STOMACH + + - - - 
26 Vasantha 65622 49 F COLORECTAL  CA - - - - + 
27 Krishnaveni 24352 35 F COLORECTAL  CA - - - - + 
28 Poonkodi 23522 38 F CA STOMACH + - - + - 
29 Muthammal 23245 26 F CA STOMACH + + - - - 
30 Kavya 24362 28 F CA STOMACH + + - - - 
1 – Pertoneal  Metastasis                        
2 – Omental Metastasis 
3 – Liver Metastasis 
4 – Ascites 
5 -Resectability 
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PROFORMA 
• NAME :        
 SL. NO: 
• AGE /SEX:  
• ADDRESS WITH CONTACT NUMBER:  
• IP NO:  
• DATE OF ADMISSION:  
• DATE OF SURGERY:  
 
HISTORY OF PRESENTING ILLNESS:  
 Pain : duration 
           Location 
            Mass 
 Vomiting     
 Nausea    
 Fever         
 Constipation/diarhoea  
              Hemetemesis , malena, weight loss 
PAST HISTORY:  
WHETHER A KNOWN CASE OF 
DM/HYPERTENSION/ASTHMA/TB/EPILEPSY/CARDIAC 
ILLNESS  
H/O SIMILAR EPISODES IN THE PAST, IF ANY: 
H/O any abdominal surgeries 
 
FAMILY HISTORY: 
 
TREATMENT HISTORY: 
CLINICAL EXAMINATION: 
 
GENERAL EXAMINATION: temp:      p.r:     bp: 
SYSTEMIC EXAMINATION: 
CVS 
RS 
           PER ABDOMEN:     soft/distended 
Mass  , size ,extent ,fixity , movement with 
respiration 
CLINICAL DIAGNOSIS: 
INVESTIGATIONS:  
Cbc: hb,tc,dc,esr ,rbs,rft,cxr,ecg, 
                     Usg  ,CECT , OGD SCOPY, COLONOSCOPY 
 
SURGERY DONE: DIAGNOSTIC LAPROSCOPY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CONSENT FOR DIAGNOSTIC LAPAROSCOPY 
Patient Name:                                        Age:                                        
Sex: M/F 
Consultant:                                            IP No: 
I have been explained about the procedure of diagnostic 
laparoscopy, where a 5mm port will be put into peritoneal cavity under 
local anaesthesia and a abdomen will be visualized for the purpose of 
tumour extension in abdominal cavity. 
I  am  aware  that  following  this  procedure  the  under  
mentioned complications could occur namely, 
1. Bleeding , Air embolism 
2. Cardiorespiratory embarrassment 
3. Hollow viscus perforation ( stomach, bowel, bladder) 
4. Solid viscus injury (Liver, spleen when grossly enlarged) 
5. Blood vessel injury (in abdominal wall & peritoneal cavity) 
I Hereby give consent for this biopsy for myself 
 Signature Name Date Time 
Patient     
Witness     
Doctor     
Interpreter     
 
